NeueHealth (NYSE:NEUE – Get Free Report) and Trupanion (NASDAQ:TRUP – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.
Insider & Institutional Ownership
63.9% of NeueHealth shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 5.8% of Trupanion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares NeueHealth and Trupanion’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NeueHealth | $1.16 billion | 0.04 | -$1.15 billion | ($151.20) | -0.04 |
| Trupanion | $1.11 billion | 0.84 | -$44.69 million | ($1.08) | -20.53 |
Volatility and Risk
NeueHealth has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and target prices for NeueHealth and Trupanion, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
| Trupanion | 0 | 3 | 1 | 0 | 2.25 |
NeueHealth currently has a consensus price target of $8.00, indicating a potential upside of 35.36%. Trupanion has a consensus price target of $33.20, indicating a potential upside of 49.75%. Given Trupanion’s stronger consensus rating and higher possible upside, analysts plainly believe Trupanion is more favorable than NeueHealth.
Profitability
This table compares NeueHealth and Trupanion’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NeueHealth | -71.23% | N/A | -1.21% |
| Trupanion | -4.03% | -15.19% | -5.95% |
Summary
Trupanion beats NeueHealth on 8 of the 14 factors compared between the two stocks.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
About Trupanion
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.
